PART 16 U.K. Amendment of Part 15 (British Pharmacopoeia)

Amendment of regulation 321 (specified publications) U.K.

218.  In regulation 321(5)—

(a) in sub-paragraph (c), insert “ UK ” before “marketing authorisation”;

[F1 (b) after sub-paragraph (c) insert—

“(ca) an EU marketing authorisation;”.]

Textual Amendments

F1 Reg. 218(b) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 178

Commencement Information

I1 Reg. 218 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1